Focal therapy of prostate cancer: energies and procedures (original) (raw)

Targeted Triple Drug Regimen for the Treatment of Prostate Cancer

Tanuja Tummala

2018

View PDFchevron_right

Treatment of localised prostate cancer with radiation therapy: evidence versus opinion

José Antonio Sánchez Calzado

Clinical and Translational Oncology, 2010

View PDFchevron_right

Radiation-based approaches for therapy and palliation of advanced prostate cancer

BRIAN LEWIS

Current Opinion in Urology, 2012

View PDFchevron_right

Radiation therapy and androgen deprivation in the management of high risk prostate cancer

Luis Souhami

International braz j urol, 2011

View PDFchevron_right

Prostate cancer survivorship

Raj Persad

Trends in Urology & Men's Health, 2014

View PDFchevron_right

Postprostatectomy radiotherapy for high-risk prostate cancer

Franz Quehenberger

2002

View PDFchevron_right

An Analysis of Patients with Clinically Localized High-Risk Prostate Carcinoma

Mack Roach

The Prostate Journal, 2000

View PDFchevron_right

High-Dose-Rate Monotherapy for Localized Prostate Cancer: 10-Year Results

Thạnh Lại Văn

International Journal of Radiation Oncology*Biology*Physics, 2016

View PDFchevron_right

Wagging the long tail of drivers of prostate cancer

Jeffrey Townsend

PLOS Genetics, 2019

View PDFchevron_right

Radical prostatectomy for carcinoma of the prostate

Thomas Wheeler

Modern Pathology, 2004

View PDFchevron_right

Clinical and Experimental Progression of a New Model of Human Prostate Cancer and Therapeutic Approach

Marie-france Poupon

The American Journal of Pathology, 2001

View PDFchevron_right

Sixteen-day schedule for intermediate and high risk prostate cancer

Francisco Casquero

Reports of Practical Oncology & Radiotherapy, 2013

View PDFchevron_right

S206 Radiation therapy for high risk subgroup of prostate cancer patients

C. Fliatouras

European Urology Supplements, 2013

View PDFchevron_right

Results of combined radiotherapy and hormonal treatment of prostate cancer patients with initial PSA value >40ng/ml

Buril Jan

Reports of Practical Oncology & Radiotherapy, 2012

View PDFchevron_right

Update on Screening in Prostate Cancer Based on Recent Clinical Trials

Vincenzo Gentile

Reviews on Recent Clinical Trials, 2011

View PDFchevron_right

Active Surveillance Compared With Initial Treatment for Men With Low-Risk Prostate Cancer

james stahl

JAMA, 2010

View PDFchevron_right

Postoperative radiotherapy in 423 patients with pT3N0 prostate cancer

Gábor József

International Journal of Radiation Oncology*Biology*Physics, 2002

View PDFchevron_right

Prostate cancer; the interface between pathology and basic scientific research

Andrew Stubbs

Seminars in Cancer Biology, 1997

View PDFchevron_right

Single Foci Prostate Cancer: Current Diagnosis and Management

Ioannis Efthimiou

Current Urology, 2013

View PDFchevron_right

Postradiation therapy adenosquamous cell carcinoma of the prostate

Mohamed Helal

Prostate Cancer and Prostatic Diseases, 2000

View PDFchevron_right

Palliative radiation therapy for localized prostate symptoms in hormone refractory prostate cancer

V DO

Australasian Radiology, 2007

View PDFchevron_right

Radiobiological comparison of two radiotherapy treatment techniques for high-risk prostate cancer

José López Torrecilla

Reports of Practical Oncology & Radiotherapy, 2013

View PDFchevron_right

Novel approaches to improve prostate cancer diagnosis and management in early‐stage disease

Jelle Barentsz

BJU International, 2012

View PDFchevron_right

Improved Outcomes with Radiation Therapy in African Americans with Prostate Cancer

Hani Ashamalla

International Journal of Radiation Oncology Biology Physics, 2019

View PDFchevron_right

1664: Pathological Assessment of High Grade Tumors in the Prostate Cancer Prevention Trial (PCPT)

Scott Lucia

The Journal of Urology, 2005

View PDFchevron_right